|
Yiqi Huoxue Chinese patent medicine for coronary heart disease with angina pectoris: an overview based the systematic review/Meta-analysis database of traditional Chinese medicine |
Hits 1007 Download times 674 Received:January 05, 2021 |
View Full Text View/Add Comment Download reader |
DOI
10.11656/j.issn.1672-1519.2021.06.15 |
Key Words
yiqi huoxue;Chinese patent medicine;coronary heart disease;angina pectoris;systematic review;Meta-analysis;overview |
Author Name | Affiliation | E-mail | JI Zhaochen | Evidence-based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | HU Haiyin | Evidence-based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | LI Nan | Evidence-based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | WANG Keyi | Evidence-based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | WANG Hucheng | Evidence-based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | ZHANG Mingyan | Evidence-based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | LI Kai | Evidence-based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | WANG Hui | Evidence-based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | LIU Chunxiang | Evidence-based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | ZHENG Wenke | Evidence-based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | ZHANG Junhua | Evidence-based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | zjhtcm@foxmail.com |
|
Abstract
|
[Objective] Base on the systematic review/Meta-analysis database of traditional Chinese medicine (SMD-TCM),the systematic review/meta-analysis of Yiqi Huoxue oral Chinese patent medicine for coronary heart disease with angina pectoris was overviewed,and to check the function of the SMD-TCM.[Methods] The systematic review/meta-analysis of Yiqi Huoxue oral Chinese patent medicine for coronary heart disease with angina pectoris was searched and overviewed by the SMD-TCM.[Results] Finally, 26 systematic review/Meta-analysis of yiqi huoxue oral Chinese patent medicine for coronary heart disease with angina pectoris were included. Evaluation results showed:All the included studies reported the efficacy of yiqi huoxue oral Chinese patent medicine in the treatment of coronary heart disease with angina pectoris. Safety reports were made in 19 studies,while 7 were not reported,and there were some problems such as unclear report,no group distinction and no reported number of patients. In terms of methodological quality and reporting standards,there are some deficiencies in the included studies,which need to be improved.[Conclusion] All functions of the SMD-TCM are running normally,which greatly reduces the time for overview,improves the efficiency of research,and saves time and human cost. |
|
|
|
|
|
|